Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide

Pauliina Nordling, Tuomas Kiviniemi, Marjatta Strandberg, Niko Strandberg, Juhani Airaksinen, Pauliina Nordling, Tuomas Kiviniemi, Marjatta Strandberg, Niko Strandberg, Juhani Airaksinen

Abstract

Objective: To examine the prognostic value of perioperative N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) in hip fracture patients.

Design: Blinded prospective cohort study.

Setting: Single centre trial at Turku University Hospital in Finland.

Participants: Inclusion criterion was admittance to the study hospital due to hip fracture during the trial period of October 2009--May 2010. Exclusion criteria were the patient's refusal and inadequate laboratory tests. The final study population consisted of 182 patients.

Primary and secondary outcome measures: NT-proBNP was assessed once during the perioperative period and later if clinically indicated, and troponin T (TnT) and ECG recordings were evaluated repeatedly. The short-term (30-day) and long-term (1000 days) mortalities were studied.

Results: Median (IQR) follow-up time was 3.1 (0.3) years. The median (IQR) NT-proBNP level was 1260 (2298) ng/L in preoperative and 1600 (3971) ng/L in postoperative samples (p=0.001). TnT was elevated in 66 (36%) patients, and was significantly more common in patients with higher NT-proBNP. Patients with high (>2370 ng/L) and intermediate (806-2370 ng/L) NT-proBNP level had significantly higher short-term mortality compared with patients having a low (<806 ng/L) NT-proBNP level (15 vs 11 vs 2%, p=0.04), and the long-term mortality remained higher in these patients (69% vs 49% vs 27%, p<0.001). Intermediate or high NT-proBNP level (HR 7.8, 95% CI 1.03 to 59.14, p<0.05) was the only independent predictor of short-term mortality, while intermediate or high NT-proBNP level (HR 2.27, 95% CI 1.30 to 3.96, p=0.004), the presence of dementia (HR 1.74, 95% CI 1.13 to 2.66, p=0.01) and higher preoperative American Society of Anesthesiologists' (ASA) classification (HR 1.59, 95% CI 1.06 to 2.38, p=0.02) were independent predictors of long-term mortality.

Conclusion: An elevated perioperative NT-proBNP level is common in hip fracture patients, and it is an independent predictor of short-term and long-term mortality superior to the commonly used clinical risk scores.

Trial registration number: NCT01015105; Results.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Kaplan-Meier estimates for survival at 30 days follow-up in patients with low, intermediate and high NT-proBNP level during index hospitalisation. NT-proBNP, N-terminal fragment of pro-B-type natriuretic peptide.
Figure 2
Figure 2
Kaplan-Meier estimates for survival at 1000 days follow-up in patients with low, intermediate and high NT-proBNP level during the index hospitalisation. NT-proBNP, N-terminal fragment of pro-B-type natriuretic peptide.

References

    1. Hietala P, Strandberg M, Strandberg N et al. . Perioperative myocardial infarctions are common and often unrecognized in patients undergoing hip fracture surgery. J Trauma Acute Care Surg 2013;74:1087–91. 10.1097/TA.0b013e3182827322
    1. Cullen MW, Gullerud RE, Larson DR et al. . Impact of heart failure on hip fracture outcomes: a population-based study. J Hosp Med 2011;6:507–12. 10.1002/jhm.918
    1. Smeets SJ, Poeze M, Verbruggen JP. Preoperative cardiac evaluation of geriatric patients with hip fracture. Injury 2012;43:2146–51. 10.1016/j.injury.2012.08.007
    1. Ogawa Y, Nakao K, Mukoyama M et al. . Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991;69:491–500. 10.1161/01.RES.69.2.491
    1. Yasue H, Yoshimura M, Sumida H et al. . Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195–203. 10.1161/01.CIR.90.1.195
    1. Hunt PJ, Richards AM, Nicholls MG et al. . Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287–96. 10.1046/j.1365-2265.1997.2361058.x
    1. Chong CP, Ryan JE, van Gaal WJ et al. . Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery. Am J Cardiol 2010;106:865–72. 10.1016/j.amjcard.2010.05.012
    1. Oscarsson A, Fredrikson M, Sörliden M et al. . N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery. Br J Anaesth 2009;103:206–12. 10.1093/bja/aep139
    1. Yun KH, Jeong MH, Oh SK et al. . Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients. Circ J 2008;72:195–9. 10.1253/circj.72.195
    1. Oscarsson A, Fredrikson M, Sörliden M et al. . Predictors of cardiac events in high-risk patients undergoing emergency surgery. Acta Anaesthesiol Scand 2009;53:986–94. 10.1111/j.1399-6576.2009.01971.x
    1. Schutt RC, Cevik C, Phy MP. Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in high-risk patients undergoing noncardiac surgery. Am J Cardiol 2009;104:137–40. 10.1016/j.amjcard.2009.03.005
    1. Dernellis J, Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 2006;92:1645–50. 10.1136/hrt.2005.085530
    1. Villacorta Junior H, Castro IS, Godinho M et al. . B-type natriuretic peptide is predictive of postoperative events in orthopedic surgery. Arq Bras Cardiol 2010;95:743–8. 10.1590/S0066-782X2010005000131
    1. Yeh HM, Lau HP, Lin JM et al. . Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005;92:1041–5. 10.1002/bjs.4947
    1. Hietala P, Strandberg M, Kiviniemi T et al. . Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture. Am J Cardiol 2014;114:193–7. 10.1016/j.amjcard.2014.04.026
    1. Airaksinen KE, Korkeila P, Lund J et al. . Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment—the FinPAC study. Int J Cardiol 2013;168:3679–82. 10.1016/j.ijcard.2013.06.022
    1. Airaksinen KE, Grönberg T, Nuotio I et al. . Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study. J Am Coll Cardiol 2013;62:1187–92. 10.1016/j.jacc.2013.04.089
    1. Kiviniemi T, Puurunen M, Schlitt A et al. . Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol 2014;113:1995–2001. 10.1016/j.amjcard.2014.03.038
    1. Lee TH, Marcantonio ER, Mangione CM et al. . Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043–9. 10.1161/01.CIR.100.10.1043
    1. Chong CP, Lim WK, Velkoska E et al. . N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery. Am J Cardiol 2012;109:1365–73. 10.1016/j.amjcard.2011.12.032

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다